No Data
StemRIM Extends Joint Research Agreement on Skin Anti-Aging Mechanisms
StemRIM Begins Phase 2 Trial for Cardiomyopathy Treatment
Stocks that moved the previous day part2: Timee, Heartseed, N.C.N, ETC.
Stock Name <Code> Closing Price on the 13th ⇒ Change from the previous day Kurazushi <2695> 3140 -115 Continuing to view negatively the abolition of the shareholder benefit system, IHI <7013> 8278 -452 Cautious views regarding defense tax increase have been conveyed. Omron <6645> 4892 -292 There seems to be a sense of completion regarding expectations for China’s policy moves. Kawasaki Heavy Industries <7012> 6410 -214 Major defense-related stocks are generally under selling pressure. Mitsubishi Heavy Industries <7011> 2291.5 -98.5 Core defense-related.
StemRIM Secures AMED Grant for Gene Therapy Development
Stocks that moved the previous day part 2: Metaplanet, Pluszero, eWeLL ETC.
Stock name <code> Closing price on the 12th ⇒ Change from the previous day Synchro Food <3963> 382 -35 Announced public offering and sale, leading to concerns about dilution and supply-demand in the short term. Pharma Foods <2929> 915 -43 Significant increase in profits in the first quarter, but the surprises are few. Tsuburaya Productions HD <2767> 1881 -32 High level of margin purchases is still noted during the decline. Fixstars <3687> 1850 -84 Related to quantum computers, saw a significant increase on the 11th.
Emerging Markets stock digest: Kaiom rebounds significantly, pluszero surges.
<4599> Stem Inc reduced by 19 to 324. The company's performance for the first quarter of the fiscal year ending July 2025 was announced; there was no business revenue (no business revenue in the same period last year), an operating loss of 0.573 billion yen (compared to an operating loss of 0.491 billion yen), a recurring loss of 0.573 billion yen (compared to a recurring loss of 0.491 billion yen), and a quarterly net loss of 0.56 billion yen (compared to a quarterly net loss of 0.467 billion yen), indicating an expanded deficit. The company's business revenue is primarily composed of milestone income due to development progress, and the proposal.